Courtney Lawrence: It’s Critical That as Blood Donor Eligibility Criteria Evolves
Courtney Lawrence, Divisional Chief Medical Officer at the American Red Cross, shared on LinkedIn:
”It’s critical that as blood donor eligibility criteria evolves, we ensure the U.S. blood supply for patients remains safe!
With supporting data from the experiences of other countries and ongoing studies of specific donor subpopulations, the FDA reduced the deferral period for blood donors with specific higher risk behaviors from 12 months to 3 months in 2020.
(In 2023, another huge stride was made in moving to Individualized Donor Assessment, replacing blanket deferrals based on gender and sexual orientation with evidence-based individual assessments of risks).
‘Despite reducing donor deferral periods for many infectious risk behaviors, HIV and HBV prevalence were stable, while HCV prevalence declined over 8 years.
Either slight or significant declines occurred from the pre-3M to 3M period for all agents.
Thus, changes in policy did not adversely impact the current safety of the blood supply with respect to the major infectious disease agents.’
Congratulations to the science teams from American Red Cross’s Transfusion Safety and Surveillance, Vitalant, OneBlood, New York Blood Center and the FDA on their collaborative publication in AABB Transfusion!”
Stay updated on the emerging with Hemostasis Today.
-
Oct 9, 2025, 06:44Gretchen Simmons: Anyone Can Have a Blood Clot - No One Knows This Better Than Carol West
-
Oct 8, 2025, 03:07Stroke Education By Rodrigo Guerrero - On Unilateral, Nonprogressive Stenosis
-
Oct 7, 2025, 15:015 Simple Exercises By Christina P. That Support Health in Antiphospholipid Syndrome
-
Oct 7, 2025, 14:39Dr Amid Karad: Help Raise Awareness on Evidence-Based INR Management for Diverse Indications
-
Oct 7, 2025, 14:27NBCA Insights with Erin VanDyke: Revealing Gaps in Blood Clot Diagnosis and Support
-
Oct 9, 2025, 07:14Ami Bhatt: The link Between Inflammation and Atherosclerotic Cardiovascular Disease Is No Longer Theoretical
-
Oct 9, 2025, 06:59Courtney Lawrence: It's Critical That as Blood Donor Eligibility Criteria Evolves
-
Oct 9, 2025, 06:55All You Need to Know About Generative AI in Medicine from Daniel Ting and Colleagues
-
Oct 9, 2025, 06:52Cihan Ay and Colleagues on Large Language Models VS Thrombosis Experts
-
Oct 9, 2025, 06:48A Neopoterian Theory of Global Bioethics from Henri-Corto Stoeklé and Christian Hervé
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 9, 2025, 07:15Hema Tallman: Imagine Needing A Treatment So Rare, So Specific, That Only Plasma-derived Medicine Can Help
-
Oct 9, 2025, 07:07Rahaf Ajaj: It’s About How Deeply Your Idea Can Reshape The World
-
Oct 8, 2025, 04:45Reza Shojaei: On The 2nd Day of IPAW 2025, Let's Focus on Patients, The Real Reason Plasma Matters!
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors